Proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase: a possible site of action of antiapoptotic drugs
- 1 April 2003
- journal article
- review article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 27 (2) , 291-301
- https://doi.org/10.1016/s0278-5846(03)00024-1
Abstract
No abstract availableKeywords
Funding Information
- Research Committee for Ataxic Disease
- Ministry of Health, Labour and Welfare
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 78 references indexed in Scilit:
- THE CENTRAL EFFECTORS OF CELL DEATH IN THE IMMUNE SYSTEMAnnual Review of Immunology, 1999
- Genetic Classification of Primary Neurodegenerative DiseaseScience, 1998
- Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in BrainScience, 1997
- A mutation in glyceraldehyde 3-phosphate dehydrogenase alters endocytosis in CHO cells.The Journal of cell biology, 1995
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Dynamic mutations hit double figuresNature Genetics, 1994
- Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer TypeNew England Journal of Medicine, 1986
- Neuropeptides in Human Memory and Learning ProcessesNeurosurgery, 1985
- Prolyl endopeptidaseLife Sciences, 1983
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982